Procter & Gamble BABY, FEMININE & FAMILY CARE — Cost incurred remained flat by 0.0% to $10.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.0%, from $12.50M to $10.00M. Over 3 years (FY 2022 to FY 2025), BABY, FEMININE & FAMILY CARE — Cost incurred shows a downward trend with a -21.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher spending on strategic projects or restructuring efforts, while a decrease indicates a reduction in non-recurring operational burdens.
This metric represents specific non-recurring or project-based operational costs attributed to the Baby, Feminine & Fami...
Peers in the consumer packaged goods industry often report these as 'restructuring charges' or 'special project expenses' within segment-level operating disclosures.
pg_segment_baby_feminine_family_care_cost_incurred| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $83.00M | $21.00M | $50.00M | $40.00M |
| YoY Change | — | -74.7% | +138.1% | -20.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.